EA200702171A1 - Фармацевтический состав для местного применения, содержащий нимесулид - Google Patents

Фармацевтический состав для местного применения, содержащий нимесулид

Info

Publication number
EA200702171A1
EA200702171A1 EA200702171A EA200702171A EA200702171A1 EA 200702171 A1 EA200702171 A1 EA 200702171A1 EA 200702171 A EA200702171 A EA 200702171A EA 200702171 A EA200702171 A EA 200702171A EA 200702171 A1 EA200702171 A1 EA 200702171A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
local application
application containing
containing nimesulide
nimesulide
Prior art date
Application number
EA200702171A
Other languages
English (en)
Russian (ru)
Inventor
Итка Фортова
Зденька Мрвова
Павлина Кристенова
Original Assignee
ЗЕНТИВА, а.с.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЗЕНТИВА, а.с. filed Critical ЗЕНТИВА, а.с.
Publication of EA200702171A1 publication Critical patent/EA200702171A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200702171A 2005-04-06 2006-04-06 Фармацевтический состав для местного применения, содержащий нимесулид EA200702171A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20050214A CZ2005214A3 (cs) 2005-04-06 2005-04-06 Topická léková forma s obsahem nimesulidu
PCT/CZ2006/000016 WO2006105741A2 (en) 2005-04-06 2006-04-06 Topical pharmaceutical formulation containing nimesulide

Publications (1)

Publication Number Publication Date
EA200702171A1 true EA200702171A1 (ru) 2008-04-28

Family

ID=37073817

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702171A EA200702171A1 (ru) 2005-04-06 2006-04-06 Фармацевтический состав для местного применения, содержащий нимесулид

Country Status (4)

Country Link
EP (1) EP1879565A2 (cs)
CZ (1) CZ2005214A3 (cs)
EA (1) EA200702171A1 (cs)
WO (1) WO2006105741A2 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2463565A (en) 2008-09-12 2010-03-24 Critical Pharmaceuticals Ltd Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
KR102086316B1 (ko) * 2019-09-09 2020-03-09 한국콜마주식회사 경피흡수성이 우수한 화장료 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2201722A1 (en) * 1994-10-05 1996-04-18 Satoru Miyata Antiinflammatory agent for external use
IN188720B (cs) * 1997-11-06 2002-11-02 Panacea Biotec Ltd
GB2340751B (en) * 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
RU2188007C2 (ru) * 1998-10-27 2002-08-27 Панацея Биотек Лимитед Новая антиаллергическая противовоспалительная композиция и способ ее получения
EP1734925A2 (en) * 2004-03-18 2006-12-27 Panacea Biotec Ltd. Novel compositions for topical delivery

Also Published As

Publication number Publication date
WO2006105741A3 (en) 2007-03-08
EP1879565A2 (en) 2008-01-23
WO2006105741B1 (en) 2007-04-19
WO2006105741A2 (en) 2006-10-12
CZ297215B6 (cs) 2006-10-11
CZ2005214A3 (cs) 2006-10-11

Similar Documents

Publication Publication Date Title
MX2008011085A (es) Composiciones antimicrobianas y metodos para sellar cateteres.
ES2527242T3 (es) Composiciones que comprenden un germinante y un agente antimicrobiano
WO2008008364A3 (en) Enhanced stability phenylephrine liquid compositions
ATE447568T1 (de) Neue pyrinderivate
HUE052378T2 (hu) Lokális topikális adagolású, indoxacarb tartalmú formulációk
NO20030929L (no) Guanidinobenzamider som MC4-R agonister
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
CL2009000882A1 (es) Un compuesto n-(4-cloro-3-(piridin-2-il)fenil)-4-(2-hidroxi-2-metilpropilsulfonil)-2-metilbenzamida, inhibidor de la via de señalización hedgehog; composición farmacéutica que comprende a dicho compuesto; y su uso para tratar el cancer.
DK1799633T3 (da) Krystalformer af (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol-hydrochlorid til anvendelse som aktivt indholdsstof i farmaceutiske sammensætninger
TW200700406A (en) Novel thiophene derivatives
ECSP077239A (es) Formulación farmacéutica
TW200716591A (en) Novel thiophene derivatives
TW200738670A (en) Novel thiophene derivatives
BRPI0509184A (pt) composições farmacêuticas
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
WO2006138735A3 (en) Gel compositions for topical administration
GT200600520A (es) Agentes antibacterianos
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
NL1028193A1 (nl) Farmaceutisch werkzame verbindingen.
DK2234645T3 (da) Peg-interferon-beta-formuleringer
NO20063393L (no) Farmasoytiske preparater
PT1906916E (pt) Suspensão oftálmica compreendendo um fármaco oftálmico, uma poloxamina e um agente de ajuste da tonicidade de glicol, utilização da referida composição para a produção de um medicamento para o tratamento de distúrbios oftálmicos
BRPI0611025A2 (pt) composto, uso de um composto, e, composição farmacêuticamente aceitável
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
BRPI0619911A2 (pt) composto, pró-droga, agente farmacêutico, e, uso do composto